12 Month Price Forecast For EXPO
Distance to EXPO Price Forecasts
EXPO Price Momentum
🤔 Considering Exponent (EXPO)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 6:37 AM UTC
EXPO Analyst Ratings & Price Targets
Based on our analysis of 4 Wall Street analysts, EXPO has a consensus that is neutral. The median price target is $116.00, with forecasts ranging from $112.00 to $120.00. Currently, there are 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
With EXPO currently trading at $92.94, the median price forecast suggests a 24.8% upside. The most optimistic forecast comes from Tobey Sommer at Truist Securities, projecting a 29.1% upside, while at provides the most conservative target, suggesting a 20.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EXPO Analyst Consensus
EXPO Price Target Range
Latest EXPO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EXPO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 26, 2024 | Truist Securities | Tobey Sommer | Buy | Reiterates | $120.00 |
| Apr 29, 2024 | Truist Securities | Tobey Sommer | Buy | Maintains | $100.00 |
| Feb 2, 2024 | Truist Securities | Tobey Sommer | Buy | Maintains | $95.00 |
| Jul 31, 2023 | Truist Securities | Tobey Sommer | Buy | Maintains | $110.00 |
| Jun 1, 2023 | UBS | Joshua Chan | Neutral | Initiates | $99.00 |
| Apr 5, 2022 | Truist Securities | Tobey Sommer | Buy | Maintains | $120.00 |
| Aug 2, 2021 | Truist Securities | Tobey Sommer | Buy | Maintains | $118.00 |
| Jun 2, 2020 | Sidoti & Co. | Buy | Maintains | $94.00 | |
| May 13, 2020 | Sidoti & Co. | Buy | Upgrade | $0.00 | |
| May 1, 2020 | Sidoti & Co. | Neutral | Maintains | $80.00 | |
| Mar 19, 2020 | Sidoti & Co. | Marc Riddick | Buy | Upgrade | $78.00 |
| Feb 7, 2020 | Sidoti & Co. | Neutral | Maintains | $74.00 | |
| Oct 3, 2019 | Sidoti & Co. | Neutral | Maintains | $72.00 | |
| Sep 20, 2019 | SunTrust Robinson Humphrey | Buy | Maintains | $81.00 | |
| Aug 29, 2019 | DA Davidson | Neutral | Initiates | $0.00 | |
| Jan 26, 2018 | SunTrust Robinson Humphrey | Buy | Upgrade | $0.00 | |
| Aug 26, 2016 | Cantor Fitzgerald | Buy | Initiates | $0.00 |
Stocks Similar to Exponent Inc
The following stocks are similar to Exponent based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Exponent Inc (EXPO) Financial Data
Exponent Inc has a market capitalization of $4.77B with a P/E ratio of 45.6x. The company generates $508.60M in trailing twelve-month revenue with a 20.9% profit margin.
Revenue growth is +0.1% quarter-over-quarter, while maintaining an operating margin of +20.7% and return on equity of +27.8%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Exponent Inc (EXPO) Company Overview
About Exponent Inc
Provides science and engineering consulting services.
Exponent, Inc. operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The company generates revenue by offering consulting services across approximately 90 technical disciplines, addressing complex challenges in various sectors including chemical, construction, and life sciences.
Founded in 1967 and headquartered in Menlo Park, California, Exponent serves a diverse range of clients including government entities and industries such as energy, technology, and manufacturing. The company's expertise spans multiple fields, providing a comprehensive suite of services that cater to pressing industry needs.
Company Information
Sector
Industrials
Industry
Engineering & Construction
Employees
949
CEO
Dr. Catherine Ford Corrigan P.E., Ph.D.
Country
United States
IPO Year
1990
Website
www.exponent.comExponent Inc (EXPO) Latest News & Analysis
Exponent, Inc. (Nasdaq: EXPO) will report Q4 and FY 2024 financial results on February 6, 2025. A conference call with executives will follow at 4:30 p.m. ET.
Exponent, Inc.'s upcoming financial results announcement and conference call may influence stock performance, providing insights into the company's growth and profitability trends.
The Zacks Consulting Services industry is expected to thrive, with strong service activities. IT, STN, and EXPO are identified as promising stocks to benefit from this demand.
Healthy service activities in the Zacks Consulting Services industry indicate growth potential, making IT, STN, and EXPO attractive investment opportunities amid rising demand.
Exponent, Inc. (NASDAQ:EXPO) will hold its Q3 2024 earnings conference call on October 24, 2024, at 4:30 PM ET, featuring key executives and analysts from major firms.
The Q3 earnings call for Exponent, Inc. will provide insights into the company's financial performance and future outlook, influencing investor sentiment and stock valuation.
Exponent (EXPO) Q3 Earnings Top Estimates
2 months agoExponent (EXPO) reported Q3 earnings of $0.50 per share, surpassing the Zacks Consensus Estimate of $0.48 and up from $0.48 per share in the same quarter last year.
Exponent's earnings beat expectations, signaling strong performance and potential growth. This could boost investor confidence and influence stock price positively.
Exponent to Announce Third Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on October 24, 2024
3 months agoExponent, Inc. (Nasdaq: EXPO) will report Q3 fiscal 2024 results on October 24, 2024, after market close, followed by a conference call at 4:30 p.m. ET.
The upcoming earnings report and conference call for Exponent, Inc. will provide insights into the company's financial health and performance, influencing stock price and investor sentiment.
Exponent (EXPO) and Cellebrite DI Ltd. (CLBT) have shown performance metrics relative to their sector in 2023. Specific performance data is not provided in the excerpt.
Performance comparison of Exponent and Cellebrite against their sector signals market trends, competitiveness, and potential investment opportunities within their respective industries.
Frequently Asked Questions About EXPO Stock
What is Exponent Inc's (EXPO) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Exponent Inc (EXPO) has a median price target of $116.00. The highest price target is $120.00 and the lowest is $112.00.
Is EXPO stock a good investment in 2025?
According to current analyst ratings, EXPO has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $92.94. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for EXPO stock?
Wall Street analysts predict EXPO stock could reach $116.00 in the next 12 months. This represents a 24.8% increase from the current price of $92.94. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Exponent Inc's business model?
Exponent, Inc. operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The company generates revenue by offering consulting services across approximately 90 technical disciplines, addressing complex challenges in various sectors including chemical, construction, and life sciences.
What is the highest forecasted price for EXPO Exponent Inc?
The highest price target for EXPO is $120.00 from Tobey Sommer at Truist Securities, which represents a 29.1% increase from the current price of $92.94.
What is the lowest forecasted price for EXPO Exponent Inc?
The lowest price target for EXPO is $112.00 from at , which represents a 20.5% increase from the current price of $92.94.
What is the overall EXPO consensus from analysts for Exponent Inc?
The overall analyst consensus for EXPO is neutral. Out of 4 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $116.00.
How accurate are EXPO stock price projections?
Stock price projections, including those for Exponent Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
